How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Gastrointestinal Malignancies
Description:
This study aims to investigate the value of 68Ga-grazytracer in predicting the efficacy of immunotherapy for gastrointestinal malignancies.
Sponsor:
Ruijin Hospital
Government Study Link:
NCT06644274 - Click here to see study onClinicalTrials.gov
68Ga-grazytracer
Isotope(s):
Target(s):
- Granzyme B
